FDA Investigator Patricia S Smith

Patricia S Smith has conducted inspections on 229 sites in 2 countries as of 10 Sep 2012. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
229
Last Inspection Date:
10 Sep 2012
Investigator Role:
FDA Investigator
Redica ID:
100008026
Countries of Inspections:
United States of America, Canada
FDA Investigators that have inspected at least one site in common with Patricia S Smith:
Amanda K Willey, Ann B Borromeo, Ann Marie Karnick, Anna E Fain, Anthony J Grace, Barbara D Wright, Betsy C Galliher, Bonnie E Conley, Bonnie E Pierson, Brian S Lynch, Bruce H Mccullough, Carmen M Chan, Cheryl G Scott, Cheryl L Watson, Claire M Minden, Clifton C Francis, Cynthia R Crocker, Cynthia R Gibson, Dana M Daigle, Dana M Klimavicz, Danielle M Maddox, David R Heiar, Deborah A Greco, Denise L Burosh, Donna D Gallien, MPH, Dr. Koffi A Amegadje, Elizabeth D Connell, Emily E Smith, George J Flynn, Jason D Abel, Jennifer Del Valle, John E Russell, Jr, Kellie R Riggs, Kenneth R Merritt, Kimberly A Dutzek, Kimberly L Mcmillan, Konsuela Y Glass, Laura L Staples, LCDR Matthew R Mcnew, MPH, REHS/RS, Leigh Anne Myers, Leon L Crawley, Linda A Gregory Duty, Linda R Kuchenthal, Marcelo O Mangalindan, Jr, Marvin D Jones, Matthew B Thomaston, Meisha R Sampson, Meisha Waters, Melanie L Drayton, Myla T Collins, Natasha N Mccants, Pamela M Thomas, Patrick C Dooley, Samantha J Bradley, Sereen Gmorgan Murray, Shirhonda D Thorn, Steven D Dittert, Traci M Armand, Wayne S Fortenberry, Wendy R Blame, Yiyue Zhang (nmi), PhD

Patricia S Smith's Documents

Publish Date Document Type Title
August, 2000 FDA 483 Compass Point Research, Inc. - Form 483, 2000-08-23
January, 2001 FDA 483 Robert C. Bourge, M.D. - Form 483, 2001-01-11
October, 2000 FDA 483 Ronald E Pruitt, MD - Form 483, 2000-10-19
November, 2003 EIR LoBuglio, Albert, MD - EIR, 2003-11-04
July, 2001 EIR ImmunoGenetics Investigational Review Board - EIR, 2001-07-09
May, 2001 FDA 483 Lentz, M. Rigdon, M.D. - Form 483, 2001-05-10
August, 2000 FDA 483 Response Compass Point Research, Inc. - Form 483R, 2001-03-02
December, 2008 EIR Robert C. Bourge, M.D. - EIR, 2008-12-17
August, 2000 EIR Compass Point Research, Inc. - EIR, 2000-08-23
January, 2003 EIR H Edward Logue, MD - EIR, 2003-01-08
October, 2002 FDA 483 Dr. Anne Campbell Family Practice - Form 483, 2002-10-24
October, 2000 FDA 483 Nashville Medical Research Institute - Form 483, 2000-10-19
October, 2003 FDA 483 Arrowsmith Eye Institute - Form 483, 2003-10-07
March, 2012 EIR Denise Yardley, M.D. - EIR, 2012-03-29
May, 2002 FDA 483 Downs, John M., MD - Form 483, 2002-05-16
April, 2000 EIR Yunus, Furhan, MD - EIR, 2000-04-11
June, 2001 EIR Patterson, William, M.D. - EIR, 2001-06-20
July, 2001 FDA 483 ImmunoGenetics Investigational Review Board - Form 483, 2001-07-09
March, 2001 EIR Heideman, Richard L., MD - EIR, 2001-03-16
April, 2000 FDA 483 Comprehensive Cancer Institute - Form 483, 2000-04-04
January, 2000 EIR Patterson, William, M.D. - EIR, 2000-01-12
June, 2000 FDA 483 Touger, M. Scott, MD - Form 483, 2000-06-07
February, 2009 FDA 483 Robert Michael Murray, MD - Form 483, 2009-02-26
August, 2001 EIR McGrew, III, Frank A., MD - EIR, 2001-08-01
June, 2002 EIR Raed A. Aqel MD - EIR, 2002-06-28
October, 2000 EIR PRUITT, RONALD E., M.D. - EIR, 2000-10-19
October, 2000 FDA 483 Response Ronald E Pruitt, MD - Form 483R, 2001-03-15
May, 2000 EIR Russell, Melvin D., M.D., Clinical Investigator - EIR, 2000-05-03
March, 2012 FDA 483 Denise Yardley, M.D. - Form 483, 2012-03-29
August, 2000 EIR Patient Advocacy Council Inc - EIR, 2000-08-23
March, 2000 FDA 483 Yearwood, Thomas, M.D. - Form 483, 2000-03-16
August, 2001 FDA 483 McGrew, III, Frank A., MD - Form 483, 2001-08-01
May, 2002 EIR Downs, John M., MD - EIR, 2002-05-16
March, 2002 FDA 483 St Thomas Hospital Medical Plaza West - Form 483, 2002-03-14
April, 2000 FDA 483 Yunus, Furhan, MD - Form 483, 2000-04-11
March, 2001 EIR St. Jude Children's Research Hospital - EIR, 2001-03-15
June, 2011 FDA 483 Edward R Arrowsmith M D - Form 483, 2011-06-24
October, 2001 FDA 483 Cezayirli, R. Cem, MD - Form 483, 2001-10-03
September, 2006 FDA 483 Runels, Charles E., Jr., MD - Form 483, 2006-09-21
October, 2002 FDA 483 Response Anne Kirkman-Campbell, MD - Form 483R, 2002-11-04
February, 2000 EIR Lawrence D Wruble, MD - EIR, 2000-02-10
April, 2000 EIR Brown, Candace, PharmD - EIR, 2000-04-14
March, 2001 FDA 483 St. Jude Children's Research Hospital IRB - Form 483, 2001-03-15
February, 2009 FDA 483 Response Robert Michael Murray, MD - Form 483R, 2009-03-31
May, 2006 FDA 483 Runels, Charles E., Jr., MD - Form 483, 2006-05-12
February, 2000 FDA 483 Lawrence D Wruble, MD - Form 483, 2000-02-10
February, 2001 EIR Chenault, Alice A., MD - EIR, 2001-02-28
February, 2001 FDA 483 Huntsville Research Associates - Form 483, 2001-02-28
February, 2000 EIR Sioson, Priscilla, B., M.D. - EIR, 2000-02-09
May, 2003 EIR Vishala Chindalore, MD - EIR, 2003-05-05
March, 2000 EIR Yearwood, Thomas, M.D. - EIR, 2000-03-16
May, 2001 FDA 483 Response Lentz, M. Rigdon, M.D. - Form 483R, 2001-05-10
January, 2001 EIR Robert C. Bourge, M.D. - EIR, 2001-01-11
August, 2000 FDA 483 Response Patient Advocacy Council Inc - Form 483R, 2001-03-02
August, 2000 FDA 483 Patient Advocacy Council Inc - Form 483, 2000-08-23
April, 2000 EIR Hon, Jeremy K. MD - EIR, 2000-04-04
October, 2000 FDA 483 Response Nashville Medical Research Institute - Form 483R, 2001-03-15
October, 2003 EIR Peter N. Arrowsmith, MD - EIR, 2003-10-07
March, 2000 EIR Harrell, Lindy E., MD,PhD - EIR, 2000-03-02
March, 2001 FDA 483 Heideman, Richard L., MD - Form 483, 2001-03-16
June, 2000 EIR Touger, M. Scott, MD - EIR, 2000-06-07
June, 2002 FDA 483 Raed A. Aqel MD - Form 483, 2002-06-28
October, 2000 EIR Ronald E Pruitt, MD - EIR, 2000-10-19
September, 2000 EIR Shergy, William J., M.D. - EIR, 2000-09-20
May, 2006 FDA 483 Response Runels, Charles E., Jr., MD - Form 483R, 2006-08-02
April, 2001 EIR Weber, Therese MD - EIR, 2001-04-05
November, 2000 EIR Davis, Jeffrey C., MD - EIR, 2000-11-15
March, 2001 FDA 483 Response St. Jude Children's Research Hospital - Form 483R, 2001-04-13
April, 2000 FDA 483 Brown, Candace, PharmD - Form 483, 2000-04-14
June, 2001 FDA 483 Patterson, William, M.D. - Form 483, 2001-06-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more